Marko Baralic

@kcs.ac.rs

Faculty of Medicine, University of Belgrade
Faculty of Medicine, University of Belgrade and University Clinical Centre of Serbia

Marko Baralic


                  Download Compact PDF  
https://researchid.co/markobaralic
Clinical Ass. Prof, Ass. Research Prof, MD, PhD, Internal medicine specialist / Nephrologist

EDUCATION

Medical Doctor - Faculty of Medicine, University of Belgrade
Ph. D -Faculty of Medicine, University of Belgrade
Internal medicine specialist -Faculty of Medicine, University of Belgrade
Neprologist - Faculty of Medicine, University of Belgrade

RESEARCH, TEACHING, or OTHER INTERESTS

Molecular Medicine, Biochemistry, Genetics and Molecular Biology, Cell Biology, Chemistry
46

Scopus Publications

Scopus Publications

  • Diagnostic, Prognostic and Therapeutic Utility of MicroRNA-21 in Ischemic Heart Disease
    Boris Burnjaković, Marko Atanasković, Marko Baralić, Aladin Altić, Emil Nikolov, Anastasija Ilić, Aleksandar Sič, Verica Stanković Popović, Ana Bontić, Selena Gajić, Sanja Stankovic
    International Journal of Molecular Sciences, 2026
    Ischemic heart disease (IHD) remains a leading cause of global morbidity and mortality despite advances in prevention, diagnosis, and therapy. Traditional clinical risk scores and biomarkers often fail to fully capture the complex molecular processes underlying atherosclerosis, myocardial infarction, and ischemic cardiomyopathy, leaving substantial residual risk. MicroRNAs have emerged as promising regulators and biomarkers of cardiovascular disease, among which microRNA-21 (miR-21) has attracted particular attention. MiR-21 is deeply involved in key pathophysiological mechanisms of IHD, including endothelial dysfunction, vascular inflammation, vascular smooth muscle cell proliferation, plaque development and vulnerability, cardiomyocyte survival, and myocardial fibrosis. Accumulating clinical evidence suggests that circulating miR-21 holds diagnostic value across the ischemic continuum, from stable coronary artery disease to acute coronary syndromes, myocardial infarction, and ischemic heart failure. Moreover, miR-21 demonstrates prognostic relevance, correlating with plaque instability, adverse remodeling, heart failure progression, and long-term cardiovascular outcomes. Preclinical studies further indicate that miR-21 represents a double-edged therapeutic target, offering cardio protection in acute ischemic injury while contributing to fibrosis and maladaptive remodeling if dysregulated. This narrative review summarizes current evidence on the diagnostic, prognostic, and therapeutic utility of miR-21 in IHD, highlighting its clinical promise as well as key limitations and future translational challenges.
  • Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review
    Milorad Stojadinovic, Slobodan Jankovic, Radica Zivkovic-Zaric, Marko Baralic, Svetlana Jovicic-Pavlovic, Ana Bontic, Nemanja Petrovic, Ana Pejcic
    European Journal of Clinical Pharmacology, 2025
  • Resolution of Proteinuria After Renal AVM Embolization with Combined ACEi and SGLT2i Therapy: A Case Report
    Ana Mijušković, Jelena Pavlović, Vladimir Cvetić, Borivoje Lukić, Ana Bontić, Selena Gajić, Kristina Filić, Ivana Mrđa, Aleksandar Sič, Nikola Trnić, Marko Baralić
    Kidney and Dialysis, 2025
    Background: Renal arteriovenous malformations (rAVMs) are rare vascular anomalies that may lead to hematuria, anemia, or acute kidney injury (AKI). Although endovascular embolization is the treatment of choice, post-procedural complications such as new-onset proteinuria may occur and require long-term management. Case Presentation: A 56-year-old man with recurrent gross hematuria and elevated serum creatinine (128 μmol/L) was diagnosed with a right rAVM and underwent successful selective embolization. Despite recovery of renal function, follow-up revealed new-onset proteinuria (2.2 g/24 h). Results: Introduction of an angiotensin-converting enzyme inhibitor (ACEi) resulted in partial improvement of proteinuria, while subsequent addition of a sodium–glucose cotransporter-2 inhibitor (SGLT2i) achieved almost complete resolution of proteinuria (0.33 g/24 h) and stable renal function (serum creatinine 93 μmol/L) after 12 months. Conclusions: This case highlights the occurrence of post-embolization proteinuria and illustrates the synergistic renoprotective effect of combined ACEi and SGLT2i therapy in a non-diabetic patient with vascular kidney disease.
  • Prognostic Value of Fibrinogen-to-Albumin Ratio and Neutrophil-to-Lymphocyte Ratio in Patients on Peritoneal Dialysis
    Selena Gajić, Ana Bontić, Aleksandar Sič, Vidna Karadžić-Ristanović, Milorad Stojadinović, Kristina Filić, Jelena Pavlović, Jovana Gavrilović, Kristina Petrović, Sanja Stanković, Nikola Trnić, Filip Simović, Pavle Popović, Svetlana Jovičić-Pavlović, Aleksandra Kezić, Marko Baralić
    Life, 2025
    Background and Objectives: Chronic inflammation (CIn) is common among peritoneal dialysis (PD) patients and contributes to adverse outcomes. However, the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and fibrinogen-to-albumin ratio (FAR) in PD remains uncertain. Methodology: In this prospective cohort study, 65 PD patients were followed for 18 months. Baseline demographic, clinical and laboratory data were collected and inflammatory indices were calculated. The composite outcome was all-cause mortality or transfer to hemodialysis (HD). Logistic regression analyses were used to identify independent predictors of outcomes. Results: Over the 18-month follow-up, 23 patients (35.4%) died and 13 (20.0%) transferred to HD. Patients with adverse outcomes had higher baseline FAR, C-reactive protein (CRP) and serum glucose (Glc) levels and lower triglycerides (TG). In multivariate analysis, higher FAR (OR 5.28, 95% CI 1.16–24.12), CRP (OR 1.28, 95% CI 1.02–1.62) and PTH (OR 1.01, 95% CI 1.00–1.01) were independently associated with adverse outcomes, while NLR showed marginal significance. In the mortality-only model, FAR (OR 3.99, 95% CI 1.17–13.61) and PTH remained significant predictors. Conclusions: FAR demonstrated a significant prognostic association with mortality and composite adverse outcomes in PD patients, whereas NLR had limited predictive value. Albumin-based inflammatory indices such as FAR may complement established markers for risk stratification. Larger multicenter studies are warranted to validate these findings.
  • COVID-19 and Superimposed Aspergillosis in a Dual Organ Recipient with Diagnosed B-Cell Lymphoproliferative Disorder: A Rare Case Report and Literature Review
    Vidna Karadžić-Ristanović, Jelena Pavlović, Voin Brković, Ana Bontić, Marko Baralić, Dragan Vasin, Maja Životić, Novica Boričić, Darko Antić, Vojin Vuković, Milan Radović
    Diseases, 2025
    Post-transplant lymphoproliferative disorder (PTLD) poses significant risks following organ transplantation, characterized by potential aggressiveness. This report aims to discuss a case of PTLD presenting as B-cell large-cell lymphoma (DLBCL) post kidney and pancreas transplantation. A 44-year-old female with type 1 diabetes underwent simultaneous cadaver kidney and pancreas transplantation. She presented with fever, night sweats, and weakness, revealing multiple lesions on CT, including in transplanted and native kidneys and pancreas. A biopsy of the transplant kidney confirmed PTLD, DLBCL subtype, with complex immunohistochemical findings. Chemotherapy (R-CHOP) was initiated but complicated by bowel perforation necessitating surgery and antibiotics, transplant renal vein thrombosis, pyelonephritis, and neutropenia. Despite the complications, the normal function of the transplanted kidney was maintained, which made it possible to implement the standard chemotherapy protocol. This case underscores the diagnostic challenges and therapeutic complexities of PTLD, specifically DLBCL, in transplant recipients. The co-infection of COVID-19 and aspergillosis in a multiple immunocompromised patient indicated a possible rapid course of the disease with global respiratory insufficiency and a fatal outcome despite all applied therapeutic modalities.
  • The Association of MicroRNA-21 with Carotid Artery Disease and Ischemic Stroke: From Pathophysiology to Clinical Implications and Potential Therapy
    Aleksandar Sič, Marko Atanasković, Alyan Ahmed, Ivan Petrović, Filip Simović, Boris Burnjaković, Una Tonković, Aarish Manzar, Simra Shadab, Selena Gajić, Danka Bjelić, Vidna Karadžić Ristanović, Marko Baralić
    Medical Sciences, 2025
    Ischemic stroke is one of the leading causes of morbidity and mortality worldwide, with carotid atherosclerosis being its key etiological factor. MicroRNA-21 (miR-21) regulates intracellular signal pathways responsible for vascular changes and ischemic brain injury, and is recognized as a potential diagnostic and prognostic biomarker. It modifies the activity of macrophages (MΦ) and vascular smooth muscle cells, causing inflammation and affecting the stability of atherosclerotic plaques. A deficiency of miR-21 in macrophages stimulates the inflammatory response and plaque growth. It promotes both the synthesis of extracellular matrix, stabilizing the plaque, and the degradation of the fibrin cap, which leads to plaque instability. The effect of miR-21 on endothelial cells differs: it stimulates both NO· synthesis and inflammation. During ischemic stroke, miR-21 demonstrates neuroprotective effects by modulating post-ischemic inflammation and protecting the integrity of the blood–brain barrier. Therapy targeting miR-21 shows potential in experimental models, but it requires cell-specific delivery and precise timing. Further research efforts should focus on the effects of miR-21 on different cell types, as well as the development of new technologies for diagnostic and therapeutic applications.
  • IgA Nephropathy in Native Kidneys: Oxford and Banff Classifications Reveal Distinct Profiles and Predict Outcomes in Pediatric and Adult Patients
    Danijel Milivojević, Gorana Nikolić, Björn Tampe, Maja Pecić, Snežana Babac, Dušan Paripović, Gordana Miloševski Lomić, Voin Brković, Marko Baralić, Aleksandar Janković, Petar Đurić, Nataša Stajić, Jovana Putnik, Sanja Radojević Škodrić, Maja Životić
    Life, 2025
    IgA nephropathy is the most common primary glomerulonephritis, with pathohistological changes described by the Oxford classification, while the Banff classification is used in transplant pathology. This study included 253 patients with IgA nephropathy in native kidneys, divided into the pediatric (n = 105) and adult (n = 148) groups. It aimed to examine clinical, and Oxford and Banff morphological parameters in relation to age, correlations of clinical data with pathohistological parameters, and predictors of the disease outcome. Pediatric patients more frequently presented with macroscopic hematuria, while adults showed higher urea and creatinine levels, and lower eGFR. Examining Oxford classification parameters, chronic glomerular and tubulointerstitial lesions were more common in adults. Banff parameters revealed more frequent chronically active glomerular, inflammatory, chronic tubulointerstitial, and vascular lesions in adults. All inflammatory, chronic tubulointerstitial, and vascular parameters correlated with serum urea levels, eGFR and CKD stage in adults, while less frequent in pediatric patients. Tubulointerstitial Oxford and Banff parameters were strong predictors of CKD and proteinuria progression in children, while such predictors were fewer in adults; segmental glomerulosclerosis predicted hematuria progression in adults. Banff parameters (cg, t, ti, i, i-IFTA, ptc, cv), not in Oxford classification, significantly predict outcomes and are recommended for incorporation into IgA nephropathy reports.
  • Laboratory, Clinical, and Pathohistological Significance of the Outcomes of Patients with Membranous Nephropathy After 10 Year of Follow-Up
    Marko Baralić, Selena Gajić, Mihajlo Kostić, Milorad Stojadinović, Kristina Filić, Danka Bjelić, Vidna Karadžić-Ristanović, Ivana Mrđa, Jovana Gavrilović, Danica Ćujić, Aleksandar Sič, Stefan Janković, Ivan Putica, Sanja Stankovic, Dušan Vićentijević, Maja Životić, Sanja Radojević-Škodrić, Jelena Pavlović, Ana Bontić, Aleksandra Kezić
    Life, 2025
    Membranous nephropathy (MN) is the most prevalent cause of nephrotic syndrome (NS) in adults, and it can be primary (idiopathic) with an unknown cause or secondary due to a variety of conditions (lupus, infections, malignancies, medications, etc.). It progresses to chronic kidney disease (CKD) in up to 60% of patients, and 10 to 30% develop end-stage kidney disease (ESKD). This retrospective study examines the importance of specific factors, including baseline demographic and clinical data, kidney biopsy PH findings, and selected biochemical parameters, influencing MN outcomes after 10 years of follow-up. The cohort included 94 individuals in whom a diagnosis of MN was established by percutaneous biopsy of the left kidney’s lower pole at the University Clinical Center of Serbia (UCCS) between 2008 and 2013. According to the outcomes, patients were divided into three groups: the recovery (Rec) group, with complete remission, including normal serum creatinine (Scr) and proteinuria (Prt), the group with development of chronic kidney disease (CKD), and the group with development of end-stage kidney disease (ESKD). Nephropathologists graded pathohistological (PH) results from I to III based on the observed PH findings. During the follow-up period, 33 patients were in the Rec group, CKD developed in 53 patients, and ESKD developed in 8 patients. Baseline creatinine clearance levels (Ccr), Scr, and uric acid (urate) were found to be significantly associated with the outcomes (p < 0.001). The lowest values of baseline Scr and urate were observed in the Rec group. The presence of acute kidney injury (AKI) or CKD at the time of kidney biopsy was associated with the more frequent development of ESKD (p = 0.02). Lower Ccr was associated with a higher likelihood of progressing to CKD (B = −0.021, p = 0.014), whereas older age independently predicted progression to ESKD (B = 0.02, p = 0.032). Based on this study, it was concluded that the most important biochemical and clinical factors that are associated with the outcomes of this disease are the values of Scr, Ccr, and urate and the existence of CKD at the time of kidney biopsy. Unlike most previous studies, the presence of HTN had no statistical significance in the outcome of the disease.
  • Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality
    Marko Baralić, Nikola Stojanović, Selena Gajić, Aleksandar Sič, Aarish Manzar, Ana Bontić, Jelena Pavlović, Mateja N. Bojić, Aleksandra Kezić
    Vaccines, 2025
    Patients undergoing peritoneal dialysis (PD) represent a uniquely vulnerable population due to intrinsic immunological dysfunction and a high prevalence of comorbid conditions. This review examines the complex interplay between natural and vaccine-induced immune responses to SARS-CoV-2 in this group, focusing on viral entry, immune activation, and immune evasion mechanisms. Particular attention is given to the impaired cellular and humoral responses seen in PD patients, including reduced T-cell function, diminished antibody production, and abnormal cytokine signaling, all of which contribute to an elevated risk of severe COVID-19 outcomes. The immunogenicity and clinical efficacy of various vaccine platforms, including inactivated, vector-based, and mRNA formulations, are critically assessed, with an emphasis on the role of booster doses in enhancing protection amid waning immunity and evolving viral variants. Furthermore, the review highlights the advantages of PD as a home-based modality that is compatible with telemedicine and may reduce the risk of viral exposure. These insights underscore the importance of developing individualized vaccination strategies, maintaining close immunological surveillance, and implementing innovative dialysis care approaches to improve clinical outcomes during the ongoing pandemic and future public health crises. Tailored booster strategies and telemedicine-integrated care models are essential for improving outcomes in this high-risk population.
  • Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review
    Una Tonkovic, Marko Bogicevic, Aarish Manzar, Nikola Andrejic, Aleksandar Sic, Marko Atanaskovic, Selena Gajić, Ana Bontić, Sara Helena Ksiazek, Ana Mijušković, Nikola M. Stojanović, Marko Baralić
    Brain Sciences, 2025
    Hemolytic uremic syndrome (HUS), a thrombotic microangiopathy primarily affecting the kidneys, can also involve the central nervous system (CNS), often leading to significant morbidity and mortality. Neurologic manifestations are among the most severe extra-renal complications, particularly in children and during outbreaks of Shiga toxin-producing Escherichia coli (STEC)-associated HUS (typical (tHUS)). This review explores the clinical spectrum, pathophysiology, diagnostic workup, and age-specific outcomes of neurologic involvement in both typical (tHUS) and atypical (aHUS). Neurologic complications occur in up to 11% of pediatric and over 40% of adult STEC-HUS cases in outbreak settings. Presentations include seizures, encephalopathy, focal deficits, movement disorders, and posterior reversible encephalopathy syndrome (PRES). Magnetic resonance imaging (MRI) commonly reveals basal ganglia or parieto-occipital lesions, though subtle or delayed findings may occur. Laboratory workup typically confirms microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and kidney damage, with additional markers of inflammation or metabolic dysregulation. Eculizumab is the first-line treatment for aHUS with CNS involvement, while its utility in STEC-HUS remains uncertain. Although many children recover fully, those with early CNS involvement are at greater risk of developing epilepsy, cognitive delays, or fine motor deficits. Adults may experience lingering neurocognitive symptoms despite apparent clinical recovery. Differences in presentation and imaging findings between age groups emphasize the need for tailored diagnostic and therapeutic strategies. Comprehensive neurorehabilitation and long-term follow-up are crucial for identifying residual deficits. Continued research into predictive biomarkers, neuroprotective interventions, and standardized treatment protocols is needed for improving outcomes in HUS patients with neurological complications.
  • Tricuspid Valve Infective Endocarditis in a Chronic Haemodialysis Patient with a Hickman Catheter: A Case Report
    Dalila Šačić, Saddam Shawamri, Ivana Jovanović, Marija Boričić-Kostić, Boris Jegorović, Miloš Mijalković, Kristina Filić, Stefan Juričić, Vidna Karadžić-Ristanović, Danka Bjelić, Selena Gajić, Marko Baralić
    Pathogens, 2025
  • Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring
    Aleksandra Kezić, Selena Gajić, Ana Račić Ostojić, Ivana Bekić, Ana Bontić, Jelena Pavlović, Marko Baralić, Ljiljana Popović
    Life, 2025
  • Stroke in Young Adults: An Overview and Non-Pharmacological Preventive Strategies
    Aleksandar Sič, Nikola Andrejić, Jovana Ivanović, Vidna Karadžić Ristanović, Selena Gajić, Danka Bjelić, Marko Baralić, Nikola Stojanovic
    Brain Sciences, 2025
  • The Effects of SGLT2 Inhibitors on Lipid Profile and Kidney Function in Patients with Chronic Kidney Disease Regardless of Diabetes and Hypertension Status
    Selena Gajić, Stefan Janković, Milorad Stojadinović, Kristina Filić, Ana Bontić, Jelena Pavlović, Ivana Mrđa, Kristina Petrović, Lara Hadži-Tanović, Jelena Žunić, Mihajlo Kostić, Aleksandra Kezić, Marko Baralić
    Metabolites, 2025
  • Natural Source of Drugs Targeting Central Nervous System Tumors—Focus on NAD(P)H Oxidoreductase 1 (NQO1) Activity
    Nikola M. Stojanovic, Milica Mitić, Jovan Ilić, Milica Radić, Miša Radisavljević, Marko Baralić, Miljan Krstić
    Brain Sciences, 2025
  • Significant Calcification of an Entire Aortic Tree with Renal Artery Subocclusion: Acute Kidney Injury, Ischemic Kidney Disease, and the Tissue Viability Question—A Case Report
    Marko Baralić, Selena Gajić, Aleksandra Kezić, Ana Bontić, Jelena Pavlović, Voin Brković, Vidna Karadžić Ristanović, Danka Bjelić, Maja Životić, Sanja Radojević-Škodrić, Želimir Antonić, Nenad Ilijevski, Milan Radović
    Life, 2025
  • Tunnel Infection and Peritonitis Induced by Staphylococcus aureus Due to Decubitus Change of the Anterior Abdominal Wall in a Patient on Peritoneal Dialysis: Case Report
    Marko Baralić, Ana Bontić, Jelena Pavlović, Vidna Karadžić-Ristanović, Selena Gajić, Jovan Jevtić, Pavle Popović, Kristina Petrović, Lara Hadži-Tanović, Aleksandra Kezić
    Microorganisms, 2024
  • Do Patients with Rheumatoid Arthritis Have an (In)Adequate Level of Physical Activity? A Latent Class Analysis Approach
    Sretko Lukovic, Marko Baralic, Nina Tomonjic, Jovana Mihailovic, Aleksandra Neskovic, Marina Vujovic Sestakov, Ivana Pavlovic, Branko Barac, Tatjana Zivanovic Radnic, Predrag Ostojic
    Life, 2024
  • Estimating Dietary Protein and Sodium Intake with Sodium Removal in Peritoneal Dialysis Patients
    Ana Bontić, Aleksandra Kezić, Jelena Pavlović, Marko Baralić, Selena Gajić, Kristina Petrovic, Vidna Karadžić Ristanović, Olga Petrović, Vera Stjepanović, Sanja Stanković, Milan Radović
    Metabolites, 2024
  • Association between nitric oxide synthase (NOS3) gene polymorphisms and diabetic nephropathy: An updated meta-analysis
    Zorana Dobrijević, Jovana Stevanović, Dragana Robajac, Ana Penezić, Danilo Četić, Marko Baralić, Olgica Nedić
    Molecular and Cellular Endocrinology, 2024
  • Glycosylation and Characterization of Human Transferrin in an End-Stage Kidney Disease
    Goran Miljuš, Ana Penezić, Lucia Pažitná, Nikola Gligorijević, Marko Baralić, Aleksandra Vilotić, Miloš Šunderić, Dragana Robajac, Zorana Dobrijević, Jaroslav Katrlík, Olgica Nedić
    International Journal of Molecular Sciences, 2024
  • Comparative Analysis of Vascular Calcification Risk Factors in Pre-Hemodialysis and Prevalent Hemodialysis Adult Patients: Insights into Calcification Biomarker Associations and Implications for Intervention Strategies in Chronic Kidney Disease
    Marko Petrović, Voin Brković, Marko Baralić, Ivko Marić, Nenad Petković, Sanja Stanković, Nataša Lalić, Dejana Stanisavljević, Ljubica Đukanović, Višnja Ležaić
    Diagnostics, 2024
  • The Importance of Natural and Acquired Immunity to SARS-CoV-2 Infection in Patients on Peritoneal Dialysis
    Marko Baralić, Mirjana Laušević, Danica Ćujić, Ana Bontić, Jelena Pavlović, Voin Brković, Aleksandra Kezić, Kristina Mihajlovski, Lara Hadži Tanović, Iman Assi Milošević, Jovana Lukić, Marija Gnjatović, Aleksandra Todorović, Nikola M. Stojanović, Dijana Jovanović, Milan Radović
    Vaccines, 2024
  • A Study on Mortality Predictors in Hemodialysis Patients Infected with COVID-19: Impact of Vaccination Status
    Voin Brkovic, Gorana Nikolic, Marko Baralic, Milica Kravljaca, Marija Milinkovic, Jelena Pavlovic, Mirjana Lausevic, Milan Radovic
    Vaccines, 2024
  • Oregano (Origanum vulgare) Essential Oil and Its Constituents Prevent Rat Kidney Tissue Injury and Inflammation Induced by a High Dose of L-Arginine
    Nikola M. Stojanović, Katarina V. Mitić, Milica Nešić, Milica Stanković, Vladimir Petrović, Marko Baralić, Pavle J. Randjelović, Dušan Sokolović, Niko Radulović
    International Journal of Molecular Sciences, 2024
  • Renal Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review of 71 Cases
    Marilia Dagnon da Silva, Sidney Marcel Domingues, Stevan Oluic, Milan Radovanovic, Pratyusha Kodela, Terri Nordin, Margaret R. Paulson, Bojan Joksimović, Omobolanle Adetimehin, Devender Singh, Cristian Madrid, Milena Cardozo, Marko Baralic, Igor Dumic
    Journal of Clinical Medicine, 2023
  • Significance of 1,25-Dihydroxyvitamin D3 on Overall Mortality in Peritoneal Dialysis Patients with COVID-19
    Marko Baralić, Dragana Robajac, Ana Penezić, Voin Brković, Nikola Gligorijević, Ana Bontić, Jelena Pavlović, Jelena Nikolić, Goran Miljuš, Zorana Dobrijević, Miloš Šunderić, Lucia Pažitná, Jaroslav Katrlík, Olgica Nedić, Mirjana Laušević
    Nutrients, 2023
  • Prediction of Mortality in Patients on Peritoneal Dialysis Based on the Fibrinogen Mannosylation
    Marko Baralić, Lucia Pažitná, Voin Brković, Mirjana Laušević, Nikola Gligorijević, Jaroslav Katrlík, Olgica Nedić, Dragana Robajac
    Cells, 2023
  • Albumin at the intersection between antioxidant and pro-oxidant in patients on peritoneal dialysis
    Marko Baralić, Ivan Spasojević, Goran Miljuš, Miloš Šunderić, Dragana Robajac, Zorana Dobrijević, Nikola Gligorijević, Olgica Nedić, Ana Penezić
    Free Radical Biology and Medicine, 2022
  • Myalgic encephalomyelitis – enigma at the medicine’s crossroads
    Dragan Pavlovic, Jelena Djordjevic, Aleksandra Pavlovic, Mirjana Stjepanovic, Marko Baralic
    Srpski Arhiv Za Celokupno Lekarstvo, 2021
  • Unrecognized tuberculosis in a patient with COVID-19
    Mihailo Stjepanovic, Slobodan Belic, Ivana Buha, Nikola Maric, Marko Baralic, Violeta Mihailovic-Vucinic
    Srpski Arhiv Za Celokupno Lekarstvo, 2021
  • Rapidly progressive pulmonary fibrosis in covid-19 pneumonia
    Mihailo Stjepanovic, Slobodan Belic, Ivana Buha, Nikola Maric, Marko Baralic, Violeta Mihailovic-Vucinic
    Srpski Arhiv Za Celokupno Lekarstvo, 2021
  • Influence of pretransplant factors on posttransplant anemia recovery rate in primary deceased donor kidney transplant recipients
    Mirjana Lausevic, Voin Brkovic, Milica Kravljaca, Marija Milinkovic, Marko Baralic, Selena Gajic, Radomir Naumovic
    Experimental and Clinical Transplantation, 2021
  • Otitis media with effusion as an initial manifestation of granulomatosis with polyangiitis
    Dragoslava Djerić, Aleksandar Perić, Bojan Pavlović, Miljan Folić, Ana Bontić, Marko Baralić, Jelena Pavlović, Milan Radović
    Sage Open Medical Case Reports, 2021
  • Neurosarcoidosis – an ever-present clinical challenge
    Mihailo Stjepanovic, Ivana Buha, Nikola Maric, Slobodan Belic, Mirjana Stjepanovic, Sanja Dimic-Janjic, Marko Baralic, Milica Stojkovic-Lalosevic, Dragana Bubanja, Violeta Mihailovic-Vucinic
    Srpski Arhiv Za Celokupno Lekarstvo, 2021
  • Not so innocent bystander – gallbladder varices without portal vein thrombosis
    Tamara Milovanovic, Igor Dumic, Ivana Ilic, Marko Baralic, Sanja Dragasevic, Milica Stojkovic-Lalosevic, Vladimir Arsenijevic
    Srpski Arhiv Za Celokupno Lekarstvo, 2020
  • Significance of acpwv for survival of hemodialysis patients
    Marko Petrovic, Marko Baralic, Voin Brkovic, Aleksandra Arsenovic, Vesna Stojanov, Natasa Lalic, Dejana Stanisavljevic, Aleksandar Jankovic, Nenad Radivojevic, Svetlana Pejanovic, Ivko Maric, Visnja Lezaic
    Medicina Lithuania, 2020
  • Fibrinogen Modification and Fibrin Formation in Patients with an End-Stage Renal Disease Subjected to Peritoneal Dialysis
    M. Baralić, D. Robajac, A. Penezić, G. Miljuš, M. Šunderić, N. Gligorijević, O. Nedić
    Biochemistry Moscow, 2020
  • Fibrinogen fucosylation as a prognostic marker of end-stage renal disease in patients on peritoneal dialysis
    Marko Baralić, Nikola Gligorijević, Voin Brković, Jaroslav Katrlík, Lucia Pažitná, Miloš Šunderić, Goran Miljuš, Ana Penezić, Zorana Dobrijević, Mirjana Laušević, Olgica Nedić, Dragana Robajac
    Biomolecules, 2020
  • Tumors of the orbit as the first manifestation of a lung and breast malignancy
    Mihailo Stjepanovic, Nikola Maric, Marko Baralic, Jasmina Maric-Zivkovic, Violeta Mihailovic-Vucinic
    Srpski Arhiv Za Celokupno Lekarstvo, 2020
  • Evaluation of treatment outcome in patients with acute-on-chronic liver failure using clinical scores
    Tamara Milovanovic, Milica Stojkovic-Lalosevic, Sanja Dragasevic, Nevena Jocic, Marko Baralic, Igor Dumic, Aleksandra Pavlovic-Markovic
    Srpski Arhiv Za Celokupno Lekarstvo, 2020
  • Various faces of the same disease: Membranous nephropathy in pregnancy – A case series
    Aleksandra Kezic, Marko Baralic, Djina Tomasevic, Sasa Kadija, Radmila Sparic
    Srpski Arhiv Za Celokupno Lekarstvo, 2019
  • Impact of intraoperative blood pressure, blood pressure fluctuation, and pulse pressure on postoperative delirium in elderly patients with hip fracture: A prospective cohort study
    Kristina Radinovic, Ljiljana Markovic Denic, Zoka Milan, Andja Cirkovic, Marko Baralic, Vesna Bumbasirevic
    Injury, 2019
  • Quantitation of active alpha-2-macroglobulin by trypsin protease zymography
    Nikola Gligorijevic, Milos Sunderic, Aleksandra Vilotic, Marko Baralic, Olgica Nedic
    Journal of the Serbian Chemical Society, 2019
  • Dual roles of the mineral metabolism disorders biomarkers in prevalent hemodilysis patients: In renal bone disease and in vascular calcification
    Marko Baralić, Voin Brković, Vesna Stojanov, Sanja Stanković, Nataša Lalić, Petar Đurić, Ljubica Đukanović, Milorad Kašiković, Milan Petrović, Marko Petrović, Milan Stošović, Višnja Ležaić
    Journal of Medical Biochemistry, 2019
  • Prognostic value of p53, c-ErbB2 and tunel data in upper urothelial carcinoma associated with Balkan nephropathy
    Marina Savin, Z. Dzamic, M. Baralic, Sanja Radojevic-Skodric, Jelena Marinkovic, V. Bumbasirevic
    Archives of Biological Sciences, 2014